Published on Medical Design Technology (http://www.mdtmag.com)

Home > GeNO gets NDA review in second NO-based device

GeNO gets NDA review in second NO-based device

Mass High Tech: The Journal of New England Technology

A new drug application for GeNO LLC’s second product designed to delivery nitric oxide to newborn babies for treatment of respiratory failure has been accepted for review by the U.S. Food and Drug Administration.

Source URL (retrieved on 05/26/2013 - 2:58am): http://www.mdtmag.com/news/2012/11/geno-gets-nda-review-second-no-based-device?qt-most_popular=0&qt-recent_content=0